Tiotropium Bromide hydrate

CAS No. 139404-48-1

Tiotropium Bromide hydrate ( BA-679 BR hydrate )

Catalog No. M17275 CAS No. 139404-48-1

Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 59 Get Quote
10MG 78 Get Quote
25MG 141 Get Quote
50MG 176 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tiotropium Bromide hydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.
  • Description
    Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.
  • Synonyms
    BA-679 BR hydrate
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    AChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    139404-48-1
  • Formula Weight
    490.43
  • Molecular Formula
    C19H22NO4S2·Br·xH2O
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    O.[Br-].[H][C@]12C[C@@H](C[C@]([H])([C@H]3O[C@@H]13)[N+]2(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Barnes PJ, et al. Life Sci, 1995, 56(11-12), 853-859.
molnova catalog
related products
  • WHI-P154

    WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM, no activity against JAK1 or JAK2, also inhibits EGFR, Src, Abl, VEGFR and MAPK, prevents Stat3, but not Stat5 phosphorylation.

  • EGF816 mesylate

    EGF816 (Nazartinib) is a potent, irreversible, mutant-selective EGFR inhibitor with Ki and Kinact of 31 nM and 0.222 min-1, respectively.

  • ICA-105574

    ICA-105574 is an activator of hERG that binds to the channel to remove inactivation, thus increasing peak current amplitude and shortening the action potential. It also modulates activation kinetics of the channel.